{"id":46168,"date":"2022-07-14T13:02:12","date_gmt":"2022-07-14T11:02:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/"},"modified":"2022-07-14T13:02:12","modified_gmt":"2022-07-14T11:02:12","slug":"abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/","title":{"rendered":"Abiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification"},"content":{"rendered":"
\n

DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc<\/a>. (NASDAQ: ABMD) announced that on Thursday, August 4, 2022, the Company will release financial results for the first quarter of the fiscal year 2023. The Company will host a conference call to discuss the results on Thursday, August 4, 2022 at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief Executive Officer and Todd Trapp, Chief Financial Officer, will host the conference call.\n<\/p>\n

<\/a><\/p>\n

\nTo listen to the call live, please tune into the webcast via https:\/\/events.q4inc.com\/attendee\/551353819<\/a> or dial (888) 330-2413 the international number is (240) 789-2721 conference ID 83972.<\/strong> <\/b>A replay of this conference call will be available until Thursday, August 11, 2022. The replay phone number is (800) 770- 2030; the international number is (647) 362- 9199.\n<\/p>\n

\nABOUT ABIOMED<\/b>\n<\/p>\n

\nBased in Danvers, Massachusetts, Abiomed, Inc. is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and\/or performing the pumping of the heart. For additional information, please visit: www.abiomed.com<\/a>.\n<\/p>\n

\nFORWARD-LOOKING STATEMENTS<\/b>\n<\/p>\n

\nThis press release contains forward-looking statements, including with respect to Abiomed’s development of existing and new products, the Company’s commercial growth, future business opportunities and pending regulatory approvals. The Company’s actual results may differ materially from those anticipated in these forward-looking statements due to a number of factors, including uncertainties related to the scope, extent and duration of the impact of the COVID-19 pandemic, development, testing and related regulatory approvals, including the possibility of future losses, complex manufacturing, high quality requirements, dependence on limited sources of supply, competition, technological changes, governmental requirements, litigation, future capital requirements and uncertainty of additional financing, and other risks and challenges detailed in the Company’s filings with the Securities and Exchange Commission (SEC), including its most recent Annual Report on Form 10-K and subsequent filings with the SEC. Readers of this press release are advised not to evaluate forward-looking statements, which reflect information available only as of the date of this release, as reliable information. The Company is under no obligation to release updates to these forward-looking statements to reflect events or circumstances occurring after the date of the release or as a result of the impact of unforeseen events.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nTodd Trapp
\n
Chief Financial Officer
\n
978-646-1680
\n
ttrapp@abiomed.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD) announced that on Thursday, August 4, 2022, the Company will release financial results for the first quarter of the fiscal year 2023. The Company will host a conference call to discuss the results on Thursday, August 4, 2022 at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46168","6":"format-standard","7":"category-industry"},"yoast_head":"\nAbiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD) announced that on Thursday, August 4, 2022, the Company will release financial results for the first quarter of the fiscal year 2023. The Company will host a conference call to discuss the results on Thursday, August 4, 2022 at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-14T11:02:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220714005218\/en\/722993\/21\/AbioLogo_TAGLINE_COLOR.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Abiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification\",\"datePublished\":\"2022-07-14T11:02:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\\\/\"},\"wordCount\":387,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220714005218\\\/en\\\/722993\\\/21\\\/AbioLogo_TAGLINE_COLOR.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\\\/\",\"name\":\"Abiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220714005218\\\/en\\\/722993\\\/21\\\/AbioLogo_TAGLINE_COLOR.jpg\",\"datePublished\":\"2022-07-14T11:02:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220714005218\\\/en\\\/722993\\\/21\\\/AbioLogo_TAGLINE_COLOR.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220714005218\\\/en\\\/722993\\\/21\\\/AbioLogo_TAGLINE_COLOR.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/","og_locale":"en_US","og_type":"article","og_title":"Abiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification - Pharma Trend","og_description":"DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD) announced that on Thursday, August 4, 2022, the Company will release financial results for the first quarter of the fiscal year 2023. The Company will host a conference call to discuss the results on Thursday, August 4, 2022 at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-14T11:02:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220714005218\/en\/722993\/21\/AbioLogo_TAGLINE_COLOR.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Abiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification","datePublished":"2022-07-14T11:02:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/"},"wordCount":387,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220714005218\/en\/722993\/21\/AbioLogo_TAGLINE_COLOR.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/","url":"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/","name":"Abiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220714005218\/en\/722993\/21\/AbioLogo_TAGLINE_COLOR.jpg","datePublished":"2022-07-14T11:02:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220714005218\/en\/722993\/21\/AbioLogo_TAGLINE_COLOR.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220714005218\/en\/722993\/21\/AbioLogo_TAGLINE_COLOR.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/abiomed-first-quarter-fiscal-2023-earnings-and-conference-call-notification\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Abiomed First Quarter Fiscal 2023 Earnings and Conference Call Notification"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46168","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46168"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46168\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}